• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Hester Biosciences Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524669
INE782E01017
452.7953188
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HESTERBIO
35.58
1667.69
EPS(TTM)
Face Value()
Div & Yield %
55.1
10
0.56
 

eClerx Services climbs after board to mull bonus shares, Q3 earnings on 28 Jan
Jan 22,2026
In addition, the earnings call for the financial results for the quarter ended December 31, 2025 will be held on January 29, 2026.

eClerx Services is engaged in providing critical business operations services to global Fortune 500 clients, including several of the world's leading companies across financial services, cable and telecommunications, retail, fashion, media & entertainment, manufacturing, travel and leisure, software, and high tech.

The company’s consolidated net profit jumped 30.62% to Rs 183.19 crore on a 20.8% increase in revenue from operations to Rs 1,004.85 crore in Q2 FY26 over Q2 FY25.